insulin vs glp-1 Science Behind GLP 1 GIP and Glucagon Receptor Agonists for Obesity Research | News & Announcements GLP-1 for weight loss vs.

Retatrutide discontinuation data is limited because the compound is still in clinical trials and long-term follow-up after cessation has not been extensively studied

We offer several options, from vitamin injections to weight loss medications, to help you reach your goals more effectively

These include the glucagon receptor, GLP-1 pathways, and GIP signalling

A 2026 systematic review of 37 studies found that discontinuing treatment was associated with weight regain of roughly half a pound per month, with researchers projecting a return to baseline weight within about 1.5 years

Selling them labeled "for research use only" is currently permitted

It is not medical or legal advice